SPL 2.22% 9.2¢ starpharma holdings limited

Bell Potter raises target to $2.20, page-5

  1. 2,065 Posts.
    lightbulb Created with Sketch. 304
    From the BP report summary --

    . COVID-19 has impacted recruitment in Phase 2 DEP-trials,
    however sites have reinitiated
    recruitment (London sites a bit slower than regional UK sites) and at this
    stage results from all the trials are expected within the next 6-7 months,
    which would serve as significant re-rating catalysts for the stock.

    I would suggest this info has come from SPL HQ
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.2¢
Change
0.002(2.22%)
Mkt cap ! $37.93M
Open High Low Value Volume
9.2¢ 9.3¢ 9.2¢ $3.349K 36.18K

Buyers (Bids)

No. Vol. Price($)
2 113072 9.2¢
 

Sellers (Offers)

Price($) Vol. No.
9.3¢ 108436 2
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.